132 related articles for article (PubMed ID: 19022501)
1. Directional BMP-2 for functionalization of titanium surfaces.
Kashiwagi K; Tsuji T; Shiba K
Biomaterials; 2009 Feb; 30(6):1166-75. PubMed ID: 19022501
[TBL] [Abstract][Full Text] [Related]
2. The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function.
Kim SE; Song SH; Yun YP; Choi BJ; Kwon IK; Bae MS; Moon HJ; Kwon YD
Biomaterials; 2011 Jan; 32(2):366-73. PubMed ID: 20880582
[TBL] [Abstract][Full Text] [Related]
3. Enhanced osteogenic promotion around dental implants with synthetic binding motif mimicking bone morphogenetic protein (BMP)-2.
Seol YJ; Park YJ; Lee SC; Kim KH; Lee JY; Kim TI; Lee YM; Ku Y; Rhyu IC; Han SB; Chung CP
J Biomed Mater Res A; 2006 Jun; 77(3):599-607. PubMed ID: 16506173
[TBL] [Abstract][Full Text] [Related]
4. Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin.
Kodama T; Goto T; Miyazaki T; Takahashi T
Int J Oral Maxillofac Implants; 2008; 23(6):1013-9. PubMed ID: 19216269
[TBL] [Abstract][Full Text] [Related]
5. Catechol-functionalized adhesive polymer nanoparticles for controlled local release of bone morphogenetic protein-2 from titanium surface.
Lee HJ; Koo AN; Lee SW; Lee MH; Lee SC
J Control Release; 2013 Sep; 170(2):198-208. PubMed ID: 23727196
[TBL] [Abstract][Full Text] [Related]
6. Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration.
Shi Z; Neoh KG; Kang ET; Poh CK; Wang W
Biomacromolecules; 2009 Jun; 10(6):1603-11. PubMed ID: 19391583
[TBL] [Abstract][Full Text] [Related]
7. Effect of oligonucleotide mediated immobilization of bone morphogenic proteins on titanium surfaces.
Schliephake H; Bötel C; Förster A; Schwenzer B; Reichert J; Scharnweber D
Biomaterials; 2012 Feb; 33(5):1315-22. PubMed ID: 22082620
[TBL] [Abstract][Full Text] [Related]
8. N-methyl pyrrolidone as a potent bone morphogenetic protein enhancer for bone tissue regeneration.
Miguel BS; Ghayor C; Ehrbar M; Jung RE; Zwahlen RA; Hortschansky P; Schmoekel HG; Weber FE
Tissue Eng Part A; 2009 Oct; 15(10):2955-63. PubMed ID: 19320543
[TBL] [Abstract][Full Text] [Related]
9. Controlled release of bone morphogenetic protein (BMP)-2 from nanocomplex incorporated on hydroxyapatite-formed titanium surface.
Bae SE; Choi J; Joung YK; Park K; Han DK
J Control Release; 2012 Jun; 160(3):676-84. PubMed ID: 22543042
[TBL] [Abstract][Full Text] [Related]
10. PLAP-1/asporin inhibits activation of BMP receptor via its leucine-rich repeat motif.
Tomoeda M; Yamada S; Shirai H; Ozawa Y; Yanagita M; Murakami S
Biochem Biophys Res Commun; 2008 Jun; 371(2):191-6. PubMed ID: 18407830
[TBL] [Abstract][Full Text] [Related]
11. Engineering, cloning, and functional characterization of recombinant LIM mineralization protein-1 containing an N-terminal HIV-derived membrane transduction domain.
Sangadala S; Okada M; Liu Y; Viggeswarapu M; Titus L; Boden SD
Protein Expr Purif; 2009 Jun; 65(2):165-73. PubMed ID: 19284982
[TBL] [Abstract][Full Text] [Related]
12. Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces.
Schuessele A; Mayr H; Tessmar J; Goepferich A
J Biomed Mater Res A; 2009 Sep; 90(4):959-71. PubMed ID: 18655137
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of human bone-derived cells grown on GRGDSP-peptide bound titanium surfaces.
Zreiqat H; Akin FA; Howlett CR; Markovic B; Haynes D; Lateef S; Hanley L
J Biomed Mater Res A; 2003 Jan; 64(1):105-13. PubMed ID: 12483702
[TBL] [Abstract][Full Text] [Related]
14. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo.
Zhou H; Qian J; Wang J; Yao W; Liu C; Chen J; Cao X
Biomaterials; 2009 Mar; 30(9):1715-24. PubMed ID: 19131102
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulations of the adsorption of bone morphogenetic protein-2 on surfaces with medical relevance.
Utesch T; Daminelli G; Mroginski MA
Langmuir; 2011 Nov; 27(21):13144-53. PubMed ID: 21958113
[TBL] [Abstract][Full Text] [Related]
16. The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding.
Hauburger A; von Einem S; Schwaerzer GK; Buttstedt A; Zebisch M; Schräml M; Hortschansky P; Knaus P; Schwarz E
FEBS J; 2009 Nov; 276(21):6386-98. PubMed ID: 19804412
[TBL] [Abstract][Full Text] [Related]
17. An artificial fusion protein between bone morphogenetic protein 2 and titanium-binding peptide is functional in vivo.
Yuasa K; Kokubu E; Kokubun K; Matsuzaka K; Shiba K; Kashiwagi K; Inoue T
J Biomed Mater Res A; 2014 Apr; 102(4):1180-6. PubMed ID: 23625448
[TBL] [Abstract][Full Text] [Related]
18. Bioprinting of growth factors onto aligned sub-micron fibrous scaffolds for simultaneous control of cell differentiation and alignment.
Ker ED; Nain AS; Weiss LE; Wang J; Suhan J; Amon CH; Campbell PG
Biomaterials; 2011 Nov; 32(32):8097-107. PubMed ID: 21820736
[TBL] [Abstract][Full Text] [Related]
19. Osteoconductive conjugation of bone morphogenetic protein-2 onto titanium/titanium oxide surfaces coated with non-biofouling poly(poly(ethylene glycol) methacrylate).
Kang SM; Kong B; Oh E; Choi JS; Choi IS
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):385-9. PubMed ID: 19767180
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin and bone morphogenetic protein-2-decorated poly(OEGMA-r-HEMA) brushes promote osseointegration of titanium surfaces.
Ren X; Wu Y; Cheng Y; Ma H; Wei S
Langmuir; 2011 Oct; 27(19):12069-73. PubMed ID: 21888364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
